The angiotensin II Type 1 receptor blocker losartan in clinical practice: a review
Open Access
- 1 November 1996
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 18 (6) , 1058-1067
- https://doi.org/10.1016/s0149-2918(96)80061-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Losartan and Low-Dose Hydrochlorothiazide in Patients With Essential HypertensionArchives of internal medicine (1960), 1996
- Effects of Losartan on a Background of Hydrochlorothiazide in Patients With HypertensionHypertension, 1995
- A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential HypertensionHypertension, 1995
- Bradykinin-mediated effects of ACE inhibitionKidney International, 1992
- Pharmacology of Nonpeptide Angiotensin II Receptor AntagonistsAnnual Review of Pharmacology and Toxicology, 1992
- Angiotensin II InhibitionJAMA, 1977
- Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patientsThe American Journal of Medicine, 1976
- ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSUREThe Lancet, 1973